Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,001 INR | -0.48% | +1.34% | +45.27% |
06/05 | Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug | MT |
29/04 | Zydus Lifesciences Limited Receives A Demand Order-In-Original for the Financial Year 2018-19 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.27% | 12.12B | |
+19.73% | 43.74B | |
+21.80% | 22.26B | |
+16.41% | 14.9B | |
+10.09% | 13.39B | |
-9.50% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.41% | 5.47B | |
+8.29% | 4.83B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Transcript : Zydus Lifesciences Limited, Q3 2024 Earnings Call, Feb 09, 2024